Zhong et al. reported that elevated ROS levels in VSMCs from human and mouse AAA tissues lead to NF-κB pathway activation and production pro-inflammatory factors (IL-6, TNF-α) [86]. The gene discussed is IL6; the disease is triple-A syndrome.